Australia markets closed

Incyte Corporation (INCY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
52.42-0.40 (-0.77%)
As of 11:45AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,695,649
3,695,649
3,394,635
2,986,267
2,666,702
Cost of revenue
255,000
255,000
207,000
150,991
131,300
Gross profit
3,440,649
3,440,649
3,187,635
2,835,276
2,535,402
Operating expenses
Research development
1,627,594
1,627,594
1,585,936
1,458,179
2,215,942
Selling general and administrative
1,161,300
1,161,300
1,002,100
739,560
516,900
Total operating expenses
2,790,939
2,790,939
2,596,009
2,234,758
2,775,643
Operating income or loss
649,710
649,710
591,626
600,518
-240,241
Interest expense
2,551
2,551
2,666
1,908
2,174
Total other income/expenses net
14,691
14,691
-99,739
-38,813
10,247
Income before tax
834,215
834,215
529,116
570,444
-232,218
Income tax expense
236,616
236,616
188,456
-378,137
63,479
Income from continuing operations
597,599
597,599
340,660
948,581
-295,697
Net income
597,599
597,599
340,660
948,581
-295,697
Net income available to common shareholders
597,599
597,599
340,660
948,581
-295,697
Basic EPS
1.89
2.67
1.53
4.30
-1.36
Diluted EPS
1.88
2.65
1.52
4.27
-1.36
Basic average shares
223,224
223,628
222,004
220,428
218,073
Diluted average shares
225,556
225,928
223,958
222,074
218,073